Neurocrine Biosciences Inc. (NB3)
Market Closed
17 Jul, 20:00
€
150. 00
-1.4
-0.9247%
€
- Market Cap
63.27 P/E Ratio
- Div Yield
20 Volume
2.29 Eps
€ 151.4
Previous Close Want to track NB3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.73 | - |
| | | 2.39 | - |
| | | 2.07 | - |
| | | 1.47 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NB3 Earnings Reports FAQ
What is the earnings per share (EPS) for NB3?
The current EPS is 2.29.
What is the company's earnings growth rate?
Neurocrine Biosciences Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Neurocrine Biosciences Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Neurocrine Biosciences Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NB3 at this time, as Neurocrine Biosciences Inc has no recent EPS data to calculate it.
